APA-ийн эшлэл(7 дахь хэвлэлт)

Hanrahan, E., Ryan, A., Mann, H., Kennedy, S., Langmuir, P., Natale, R., . . . Heymach, J. (2009). Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.

Чикаго-гийн эшлэл (17 дахь хэвлэлт)

Hanrahan, E., A. Ryan, H. Mann, S. Kennedy, P. Langmuir, R. Natale, R. Herbst, B. Johnson, ба J. Heymach. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.

MLA -ийн эшлэл (9 дэх хэвлэлт)

Hanrahan, E., et al. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.